Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
04 2021
Historique:
received: 08 10 2020
accepted: 27 12 2020
pubmed: 3 2 2021
medline: 18 9 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Higher resting heart rate (rHR) and lower heart rate variability (HRV) are associated with increased risk of cardiovascular disease (CVD) and all-cause mortality in people with and without diabetes. It is unknown whether temporal changes in rHR and HRV may contribute to this risk. We investigated associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants' baseline glycemic state. In this prospective, population-based cohort study we investigated 4,611 CVD-free civil servants (mean [SD] age, 60 [5.9] years; 70% men). We measured rHR and/or six indices of HRV. Associations of 5-year change in 5-min rHR and HRV with fatal and nonfatal CVD and all-cause mortality or the composite of the two were assessed, with adjustments made for relevant confounders. Effect modification by glycemic state was tested. At baseline, 63% of participants were normoglycemic, 29% had prediabetes, and 8% had diabetes. During a median (interquartile range) follow-up of 11.9 (11.4; 12.3) years, 298 participants (6.5%) experienced a CVD event and 279 (6.1%) died of non-CVD-related causes. We found no association between 5-year changes in rHR and HRV and future events. Only baseline rHR was associated with all-cause mortality. A 10 bpm-higher baseline HR level was associated with an 11.4% higher rate of all-cause mortality (95% CI 1.0-22.9%; Changes in rHR and HRV and possibly also baseline values of these measures are not associated with future CVD or death in people with or without dysglycemia.

Identifiants

pubmed: 33526428
pii: dc20-2490
doi: 10.2337/dc20-2490
pmc: PMC7985416
doi:

Banques de données

figshare
['10.2337/figshare.13526351']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012-1019

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL036310
Pays : United States
Organisme : British Heart Foundation
ID : RG/16/11/32334
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG013196
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056477
Pays : United States
Organisme : British Heart Foundation
ID : RG/13/2/30098
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : K013351
Pays : United Kingdom
Organisme : British Heart Foundation
ID : NH/16/2/32499
Pays : United Kingdom

Informations de copyright

© 2021 by the American Diabetes Association.

Références

Int J Epidemiol. 2014 Jun;43(3):866-77
pubmed: 24464190
Nutr Metab Cardiovasc Dis. 2015 Jan;25(1):93-9
pubmed: 25171899
BMC Med Res Methodol. 2009 Jul 28;9:57
pubmed: 19638200
J Clin Endocrinol Metab. 2015 Jun;100(6):2443-8
pubmed: 26047073
Diabetes Care. 2010 Jul;33(7):1578-84
pubmed: 20215456
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Lancet. 2018 Jun 16;391(10138):2430-2440
pubmed: 29784146
Am Heart J. 2010 Apr;159(4):612-619.e3
pubmed: 20362720
Lancet. 2008 Sep 6;372(9641):817-21
pubmed: 18757091
Epidemiology. 2017 Sep;28(5):735-739
pubmed: 28570383
Diabetologia. 2012 May;55(5):1283-90
pubmed: 22286552
Circulation. 1996 Dec 1;94(11):2850-5
pubmed: 8941112
Science. 1984 Oct 12;226(4671):180-2
pubmed: 6484569
Am J Cardiol. 1990 Nov 1;66(15):1049-54
pubmed: 2220630
Nat Rev Endocrinol. 2011 Jul 12;7(11):682-90
pubmed: 21750507
Arch Intern Med. 1999 Mar 22;159(6):585-92
pubmed: 10090115
J Am Heart Assoc. 2014 May 08;3(3):e000668
pubmed: 24811610
Am Heart J. 1987 Jun;113(6):1489-94
pubmed: 3591616
J Clin Epidemiol. 2010 Jul;63(7):721-7
pubmed: 20338724
Int J Epidemiol. 2005 Apr;34(2):251-6
pubmed: 15576467
J Epidemiol. 2015;25(9):583-91
pubmed: 26277879
Lancet. 2010 Sep 11;376(9744):875-85
pubmed: 20801500
Clin Res Cardiol. 2014 Feb;103(2):149-59
pubmed: 24356937
Diabetes Care. 2003 May;26(5):1553-79
pubmed: 12716821
Ann Med. 2017 Feb;49(1):32-41
pubmed: 27534940
Diabetes Care. 2008 Mar;31(3):556-61
pubmed: 18086873
Stat Med. 2007 Jul 10;26(15):3018-45
pubmed: 17177166
Diabetes. 2016 May;65(5):1370-9
pubmed: 26895792
Lancet. 2009 Jun 27;373(9682):2215-21
pubmed: 19515410
Eur Heart J. 2015 Mar 1;36(9):551-9
pubmed: 24670711
J Am Heart Assoc. 2016 Feb 12;5(2):
pubmed: 26873682
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Circulation. 2000 Sep 12;102(11):1239-44
pubmed: 10982537
PLoS Med. 2013;10(7):e1001479
pubmed: 23843750
Diabetes Care. 2017 Jan;40(1):94-100
pubmed: 27803120
Circulation. 2003 May 6;107(17):2190-5
pubmed: 12695289
Atherosclerosis. 2012 Jan;220(1):194-200
pubmed: 21763655
J Am Coll Cardiol. 2010 Dec 7;56(24):1973-83
pubmed: 21126638
Diabetes Care. 2019 May;42(5):867-874
pubmed: 30940642

Auteurs

Christian S Hansen (CS)

Steno Diabetes Center Copenhagen, Gentofte, Denmark chan0583@regionh.dk.
National Institute of Public Health, Southern Denmark University, Odense, Denmark.

Marit E Jørgensen (ME)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Marek Malik (M)

National Heart and Lung Institute, Imperial College, London, U.K.
Department of Internal Medicine and Cardiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Daniel R Witte (DR)

National Institute of Public Health, Southern Denmark University, Odense, Denmark.
Department of Public Health, Aarhus University, Aarhus, Denmark.
Danish Diabetes Academy, Odense, Denmark.
Steno Diabetes Center Aarhus, Aarhus, Denmark.

Eric J Brunner (EJ)

Department of Epidemiology and Public Health, University College London, London, U.K.

Adam G Tabák (AG)

Department of Epidemiology and Public Health, University College London, London, U.K.
Department of Internal Medicine and Oncology, Semmelweis University Faculty of Medicine, Budapest, Hungary.
Department of Public Health, Semmelweis University Faculty of Medicine, Budapest, Hungary.

Mika Kivimäki (M)

Department of Epidemiology and Public Health, University College London, London, U.K.

Dorte Vistisen (D)

Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH